COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Risk / World Health Organization (WHO)
CompletedOBSERVATIONAL
Enrollment
204
Participants
Timeline
Start Date
September 22, 2023
Primary Completion Date
April 1, 2024
Study Completion Date
April 1, 2024
Conditions
Sars-CoV-2 InfectionMIS-C
Trial Locations (1)
94000
ACTIV, Créteil
All Listed Sponsors
lead
Association Clinique Thérapeutique Infantile du val de Marne
OTHER
NCT06255860 - COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Risk / World Health Organization (WHO) | Biotech Hunter | Biotech Hunter